Gabapentin
Product Images NDC 70166-751

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70166-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lohxa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display (Gabapentin300 20191219 201208)

Principal Display (Gabapentin300 20191219 201208)
This is a description of a gabapentin 300mg oral solution for oral use. The NDC number is 70166-751-06, and it is only for prescription use. Each 5mL of the solution contains 250mg of gabapentin. The solution needs to be refrigerated at a temperature of 2 to 8 °C (36 to 46 °F). The packaging is from Lohxa, located in Worcester, MA. Dosage and administration information is contained in the insert. This is intended for institutional use only.*
FDA Label Image

Equation (Figure 01)

Equation (Figure 01)
This is a formula for calculating creatinine clearance (CLCr), which is an estimate of the kidney function. The formula takes into account the patient's age and weight, as well as their serum creatinine levels (in mg/dL). Female patients need to multiply the result by 0.85.*
FDA Label Image

Chemical Structure (Figure 02)

FDA Label Image

Figure 1 (Figure 03)

FDA Label Image

Figure 2 (Figure 04)

FDA Label Image

Figure 3 (Figure 05)

FDA Label Image

Figure 4 (Figure 06)

FDA Label Image

Logo (Figure 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.